Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...
In the fourth quarter, lower sales of BIIB's multiple sclerosis drugs and Spinraza are likely to have been offset by revenues from new drugs.
At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. (Operator Instructions) Today's conference is being recorded. Thank you. I ...
Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...
Silvio Borges dos Santos Fachim assume a liderança do Departamento Jurídico da farmacêutica, trazendo quase 20 anos de ...
Estadão on MSN4d
Alto Escalão: Grupo SBF sob novo comandoEm abril, o CEO do Grupo SBF será Gustavo Furtado, vindo da Centauro e que sucede Pedro Zemel. Gustavo Furtado. Foto: ...
Also in today’s newsletter, Foxconn confirms interest in Nissan stake and Disney cuts diversity category from executive pay ...
EU Mid-Market Update: Another session with volatility weighted to second half of day as market waits for first US CPI reading ...
Pela primeira vez, a Biogen Brasil, empresa líder global em biotecnologia, é certificada pelo Great Place To Work®. O prêmio é baseado no que os funcionários dizem a respeito de sua experiência de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback